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The distinct feature of hepatitis C virus (HCV) infection is a high incidence of chronicity. The reason for
chronic HCV infection has been actively investigated, and impairment of innate and adaptive immune re-
sponses against HCV is proposed as a plausible cause. Whereas functional impairment of HCV-specific T cells
is well characterized, the role and functional status of natural killer (NK) cells in each phase of HCV infection
are still elusive. We therefore investigated whether direct interaction between NK cells and HCV-infected cells
modulates NK cell function. HCV-permissive human hepatoma cell lines were infected with cell culture-
generated HCV virions and cocultured with primary human NK cells. Cell-to-cell contact between NK cells and
HCV-infected cells reduced NK cells’ capacity to degranulate and lyse target cells, especially in the CD56dim
NK cell subset, which is characterized by low-density surface expression of CD56. The decrease in degranu-
lation capacity was correlated with downregulated expression of NK cell-activating receptors, such as NKG2D
and NKp30, on NK cells. The ability of NK cells to produce and secrete gamma interferon (IFN-) also
diminished after exposure to HCV-infected cells. The decline of IFN- production was consistent with the
reduction of NK cell degranulation. In conclusion, cell-to-cell contact with HCV-infected cells negatively
modulated functional capacity of NK cells, and the inhibition of NK cell function was associated with
downregulation of NK-activating receptors on NK cell surfaces. These observations suggest that direct cell-
to-cell interaction between NK cells and HCV-infected hepatocytes may impair NK cell function in vivo and
thereby contribute to the establishment of chronic infection.
Hepatitis C virus (HCV) is an important human pathogen
related to chronic hepatitis, liver cirrhosis, and hepatocellular
carcinoma (13). Of infected patients, 60% to 80% develop
chronic hepatitis, which is thought to be a result of impairment
of innate and adaptive immune responses (28, 29). Although
many aspects of functional impairment in the adaptive immune
response to HCV infection are revealed, the role and function
of natural killer (NK) cells in the innate immune response to
HCV infection is unclear so far (16, 28).
NK cells direct the innate immune response in virus infec-
tion by killing infected cells and secreting cytokines, such as
gamma interferon (IFN-), which inhibits viral replication
(22). The antiviral activity of NK cells is controlled by the
integration of activating and inhibitory signals. Target cells that
are distressed by virus infection display activating ligands on
their surfaces, and binding of the ligands to activating recep-
tors on NK cells leads to activation of NK cells and lysis of
infected target cells (20, 37). To overcome antiviral NK cell
responses, viruses have developed strategies to impair interac-
tion between NK cell-activating receptors and their ligands.
For example, human cytomegalovirus (HCMV) evades NK cell
responses through inhibiting expression of major histocompat-
ibility complex (MHC) class I-related chain B (MICB), UL-16
binding protein 1 (ULBP-1), and ULBP-2, which are ligands
for activating receptor NKG2D, on the surface of infected cells
(19). On the other hand, inhibition of activating receptor ex-
pression on NK cell surfaces may also suppress NK cell re-
sponses (39). Because they are readily involved in the activa-
tion of resting NK cells (5), a reduced display of constitutively
expressed activating receptors, such as NKG2D, NKp30,
NKp46, DNAM-1, and 2B4, may dampen the functional ca-
pacity of NK cells to fight against viral infection. Cytokines
secreted in response to HCMV infection indeed inhibit
NKG2D expression on the surface of NK cells and limit the
ability of NK cells to exert cytotoxicity against target cells (25).
The prominent role of NK cells in the innate immune re-
sponse to virus infection has prompted studies of the NK cell
phenotype and functional properties in HCV infection. These
include in vitro studies using HCV replicon systems, expression
vectors encoding HCV proteins, and recombinant HCV pro-
teins (9, 12, 24, 35, 36). For various reasons, these studies
yielded contradictory results (12, 24, 35). It is difficult to inter-
pret interaction between NK cells and HCV-infected cells in
noninfectious models, which do not completely simulate the
natural life cycle of HCV (19). Ex vivo studies using peripheral
blood mononuclear cells (PBMCs) from patients with hepatitis
C also showed discrepancies in the functional status of NK
cells in HCV infection (1, 11, 15, 26, 27, 30).
Though small-animal models for immunologic research are
not readily available yet, recently developed cell culture sys-
tems that generate infectious HCV virions in vitro provide
more physiological settings in which to study interaction be-
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tween HCV and the innate immune system precisely (21, 38,
41). Prior to introduction of the HCV cell culture systems,
researchers used recombinant envelope proteins which were
immobilized on the surface of a plate to investigate the effect
of HCV envelope proteins on the NK cell function. Those
studies showed that envelope protein E2 inhibits NK cells in
vitro (9, 36). The recombinant E2 cannot, however, completely
represent natural E2 proteins that are immobilized on the lipid
bilayer envelope of HCV virions. In fact, naturally expressed
E2 proteins on the surface of cell culture-generated infectious
HCV particles do not inhibit NK cell function (8, 40), unless
the cell-free virions themselves are immobilized and concen-
trated on the surface of a plate (8). This shows the utility of
HCV cell culture systems for a close examination of interaction
between HCV and immune cells. The importance of employ-
ing HCV virions is also proved by a recent report that describes
inhibition of NKG2D-dependent NK cell responses by HCV
nonstructural protein 5A (NS5A). It suggested that NS5A may
be released from hepatoma cell line Huh7.5.1 which is infected
with cell culture-generated HCV, and the released NS5A in-
hibits NK cell function through an imbalance of inflammatory
cytokines (30).
Even if cell-free HCV particles may affect NK cell function
in a specific micromilieu that immobilizes and concentrates the
virions and extracellular NS5A may suppress NK cells after
release from HCV-infected hepatocytes, the cell-to-cell con-
tact of NK cells with HCV-infected hepatocytes may also in-
hibit NK cell function in a more general and direct way. The
discovery of modulatory effects of HCV proteins on innate
immune responses of infected hepatocytes (10) suggests that
the virus may control NK cell function through regulatory
pathways of infected hepatocytes. We therefore investigated
whether HCV modulates NK cell function through direct in-
teraction of NK cells with HCV-infected hepatocytes. To in-
vestigate this precisely, we evaluated changes in NK cell func-
tion after interplay with HCV-infected cells in vitro. Cell-to-cell
contact with HCV-infected Huh7 or Huh7.5 cells significantly
reduced NK cell degranulation, target cell lysis, and IFN-
secretion. The reduction of degranulation correlated with the
reduced expression of NK cell-activating receptors, such as
NKG2D and NKp30, on the surface of NK cells.
MATERIALS AND METHODS
Generation of HCV. HCV (genotype 2a, JFH1 strain) was produced as de-
scribed previously (40). The JFH1 expression construct (provided by T. Wakita,
National Institute of Infectious Diseases, Tokyo, Japan) was linearized, and
full-length JFH1 RNA was transcribed using a MEGAscript T7 in vitro tran-
scription kit (Ambion, Austin, TX). Huh7.5 cells (provided by C. Rice, The
Rockefeller University, New York, NY) were transfected with the transcribed
RNA using DMRIE-C reagent (Invitrogen, Carlsbad, CA). The supernatant
collected from HCV RNA-transfected Huh7.5 cells was used to infect naïve
Huh7.5 cells to make HCV stocks. The supernatant of HCV-infected Huh7.5
cells was filtered through 0.45-m-pore-size syringe filters (Millipore, Billerica,
CA) and concentrated using Centricon Plus-70 (Millipore). HCV titer was de-
termined as previously described (17).
Isolation of primary human NK cells. PBMCs were isolated from buffy coats
of healthy, HCV-negative individuals by applying a Ficoll-Paque (GE Healthcare
Life Sciences, Piscataway, NJ) density gradient. Separated PBMCs were frozen
and stored in a liquid nitrogen tank. All donors were informed for research use
of their blood and gave written consent under protocols approved by the insti-
tutional review boards of Yonsei University Health System.
Frozen PBMCs were thawed later and suspended in RPMI 1640 medium
supplemented with 10% fetal bovine serum (FBS), 100 IU/ml penicillin, 100
g/ml streptomycin, and 2.05 mM L-glutamine (HyClone, South Logan, UT) in
the presence of 50 U/ml Benzonase (Novagen, Madison, MI), which was added
to remove DNA released from dead cells and to prevent clumping of PBMCs (6).
Cells were centrifuged and supernatant was removed. After washing with com-
plete RPMI medium without Benzonase, PBMCs were resuspended in complete
RPMI medium at approximately 4  106 cells/ml. Cells were rested without any
stimulation at 37°C in a CO2 incubator overnight.
Primary human NK cells were isolated from the rested PBMCs by negative
selection using a human NK cell isolation kit (Miltenyi Biotec, Bergisch
Gladbach, Germany) according to the manufacturer’s instructions. The purity of
isolated NK cells was measured by flow cytometry after staining the cells with
anti-CD3-fluorescein isothiocyanate (FITC) and anti-CD56-phycoerythrin (PE)
antibodies (BD Biosciences, San Jose, CA). When the frequency of
CD3CD56 cells was above 90% and that of CD3 cells was less than 1%,
isolated cells were used for subsequent experiments.
Analysis of NK cell degranulation. Huh7 and Huh7.5 cells were suspended in
Dulbecco’s modified Eagle medium supplemented with 10% FBS, 100 IU/ml
penicillin, and 100 g/ml streptomycin (HyClone) and seeded in 96-well flat-
bottom plates (Nunc, Roskilde, Denmark) at 1 104 cells per well. The next day,
Huh7 and Huh7.5 cells were infected with HCV at a multiplicity of infection
(MOI) of 10 and an MOI of 1, respectively. Three days after infection, when NK
cell responses peak in general virus infections in vivo (23), supernatant was
removed from the culture wells, and NK cells in complete RPMI medium were
added to the infected cells at approximately a 1:1 ratio. Recombinant human
interleukin 12 (IL-12) (PeproTech, Rocky Hill, NJ) was added to the culture
wells for some experiments. To assess direct cytotoxicity of NK cells against
HCV-infected cells, NK cells were cocultured with uninfected or HCV-infected
Huh7 or Huh7.5 cells for 4 h in the presence of 20 l/ml anti-CD107a-FITC or
anti-CD107a-PE antibodies (BD Biosciences). After the coculture, cells were
stained with anti-CD56-PE-Cy7 antibody (BD Biosciences). To evaluate changes
in the degranulation capacity of NK cells, NK cells were first cocultured with
uninfected or HCV-infected cells for 18 h, and the NK cells were harvested and
further cocultured with the same number of K562 cells in the presence of
anti-CD107a in 96-well round-bottom plates (Corning Inc., Corning, NY) for 4 h.
After the coculture with K562 target cells, NK cells were stained with anti-CD56-
PE-Cy7 antibody. Cells were fixed with 4% paraformaldehyde and analyzed with
an LSR II flow cytometer (BD Biosciences) and FlowJo software (Tree Star,
Ashland, OR). NK cell subsets were selectively analyzed by exclusively gating on
CD56dim or CD56bright NK cells among total NK cells by using the analysis
software.
Analysis of target cell lysis by NK cells. A specific lysis assay was performed as
previously reported (33). To assess direct cytolytic activity of NK cells against
HCV-infected cells, uninfected or HCV-infected Huh7.5 cells were harvested
after 72 h postinfection and labeled with a PKH-26 red fluorescent cell linker kit
according to the manufacturer’s instructions (Sigma-Aldrich, Saint Louis, MO).
PKH-26-stained Huh7.5 cells were then cocultured with NK cells for 4 h in
96-well round-bottom plates at effector-to-target (E:T) ratios of 10:1, 5:1, 2.5:1,
and 1.25:1. To evaluate changes in the cytolytic capacity of NK cells, NK cells
were cocultured with uninfected or HCV-infected Huh7.5 cells for 18 h. NK cells
were then harvested and cocultured with PKH-26-stained K562 cells for 4 h in
96-well round-bottom plates at E:T ratios of 5:1, 2.5:1, and 1.25:1. After the
coculture, cells were stained with 0.2 M TO-PRO-3–iodide (Invitrogen) to
identify permeabilized target cells. Stained cells were analyzed by flow cytometry.
Percent specific lysis was calculated as follows: (% TO-PRO-3PKH-26 K562
cells in coculture  % TO-PRO-3PKH-26 K562 cells in medium)/(% TO-
PRO-3PKH-26 K562 cells in detergent  % TO-PRO-3PKH-26 K562
cells in medium)  100.
Analysis of IFN- production. NK cells were cocultured with uninfected or
HCV-infected Huh7 or Huh7.5 cells for 18 h, and then the NK cells were
harvested and added to 96-well round-bottom plates. To detect IFN- secretion,
NK cells were stimulated with the same number of K562 cells and 1 ng/ml IL-12
for 6 h. To measure intracellular IFN-, NK cells were treated with the same
number of K562 cells, 10 ng/ml IL-12, and 100 ng/ml IL-15 (ATGen, Seongnam,
South Korea) in the presence of brefeldin A (BD Biosciences) for 6 h. After the
stimulation, supernatant was collected from the cultures and immediately stored
at 20°C for later cytokine analysis or cells were fixed and permeabilized with
Cytofix/Cytoperm solution (BD Biosciences). Secreted IFN- was measured with
a human IFN- enzyme-linked immunosorbent assay kit (PBL Interferon
Source, Piscataway, NJ) according to the manufacturer’s instructions. Intracel-
lular IFN- was detected by staining with Alexa Fluor 488-conjugated anti-IFN-
antibody (BD Biosciences) and flow cytometry.
Contact-free coculture. Huh7 cells were seeded in 12-well culture plates (BD
Biosciences) at 1.2  105 cells per well and infected with HCV. Seventy-two
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hours postinfection, filter well inserts (Transwell; Corning) containing NK cells,
the number of which was approximately the same as that for Huh7 cells, were
inserted into the 12-well plates. After an 18-h contact-free coculture, NK cell
degranulation was assessed.
Analysis of NK ligand and NK receptor expression. To determine the effect of
HCV infection on NK ligand expression, Huh7 and Huh7.5 cells were infected
with the virus. Seventy-two hours postinfection, cells were stained with combi-
nations of anti-HLA-ABC-PE, anti-HLA-E-PE, anti-PVR-PE (eBioscience, San
Diego, CA), anti-MICA/B-Alexa Fluor 647, anti-TRAIL-PE (BioLegend, San
Diego, CA), anti-ULBP-1–PE, anti-ULBP-2–APC, and anti-ULBP-3 (R&D Sys-
tems, Minneapolis, MN) antibodies, followed by DyLight 649-conjugated F(ab)2
goat anti-mouse IgG (Jackson ImmunoResearch, West Grove, PA). To deter-
mine changes in NK receptor expression induced by HCV-infected cells, NK
cells were cocultured with uninfected or HCV-infected Huh7 or Huh7.5 cells and
stained with anti-CD158a-FITC, anti-CD158b-PE, anti-NKG2D-APC, anti-
DNAM-1–PE, anti-CD56-PE-Cy7 (BD Biosciences), anti-NKp46-PE, anti-
NKp30-APC, anti-2B4-APC (BioLegend), anti-NKG2A-PerCP (R&D Systems),
and anti-KLRG1 (Abnova, Taipei, Taiwan) antibodies followed by DyLight
649-conjugated F(ab)2 goat anti-mouse IgG. Cells were fixed with 4% paraform-
aldehyde and analyzed by flow cytometry.
Statistical analysis. Paired Student’s t tests and repeated-measures analysis of
variance (ANOVA) with ad hoc Newman-Keuls multiple comparison tests were
performed using GraphPad Prism (GraphPad Software, San Diego, CA). Two-
sided P values less than 0.05 were considered statistically significant.
RESULTS
NK cells are unable to exert cytotoxicity against HCV-in-
fected hepatoma cell lines. Because functional inhibition of
NK cells would limit their ability to degranulate and release
cytotoxic molecules from cytotoxic granules upon encounter
with virus-infected target cells, NK cell degranulation during
contact with HCV-infected cells was assessed by measuring the
surface expression of CD107a, which is exposed on the NK cell
surface when cytotoxic granules fuse with the plasma mem-
brane (2). After a 4-h coculture with HCV-infected Huh7 or
Huh7.5 cells, NK cells showed no or low expression of CD107a
(Fig. 1A) and CD25, which is an activation marker for NK cells
(Fig. 1B). It appeared that HCV-infected cells were protected
from NK cell-mediated killing through suppressing NK cell
activation and degranulation. To confirm whether this obser-
vation is associated with target cell lysis, we performed a spe-
cific lysis assay. Consistent with direct degranulation activity
against HCV-infected cells (Fig. 1A), NK cells did not exert
cytolytic activity against HCV-infected Huh7.5 cells (Fig. 1C).
Huh7 and Huh7.5 cells, which are human hepatoma cell lines,
however, might inhibit NK cells by themselves (14) and impair
NK cell function regardless of HCV infection. If this was the
case, activation of NK cells by HCV-infected cells would be
masked even though it might in fact exist.
Cytotoxic capacity of NK cells is reduced after interaction
with HCV-infected cells. To exclude possible inhibitory effects
of the tumor cell lines, we employed an experimental strategy
used by ex vivo studies which evaluate functional status and
capacity of NK cells collected from HCV-infected patients (1,
3, 27). NK cells which interacted with uninfected or HCV-
infected Huh7 or Huh7.5 cells were harvested and cocultured
with K562 cells to evaluate their functional status and capacity
after contact with HCV-infected cells. The interaction of NK
cells with uninfected Huh7 or Huh7.5 hepatoma cell lines
indeed reduced their degranulation capacity. NK cells which
interacted with HCV-infected Huh7 or Huh7.5 cells showed,
however, far less degranulation than NK cells that interacted
with uninfected cells (Fig. 2A and B). In accordance with the
changes in degranulation capacity after exposure to HCV-
infected cells, interaction with HCV-infected Huh7.5 cells re-
duced the cytolytic capacity of NK cells (Fig. 2C). It is unlikely,
however, that the NK inhibitory signal is activated or the num-
ber of inhibitory receptors on the NK cells is increased, as the
inhibitory NK cell immunological synapse (17) may not form
between NK cells and K562 cells, which do not express NK
inhibitory ligands, such as HLA-ABC and HLA-E (14). In-
stead, the observation suggested that NK cells’ ability to re-
spond to activating stimuli decreased.
Importantly, the reduced functional capacity was not related
to homeostatic downregulation of NK cell activity or exhaus-
tion of NK cells following initial activation and degranulation,
because coculture of NK cells with HCV-infected Huh7 or
Huh7.5 cells for 4 h did not result in an initial increase of
degranulation and CD25 expression (Fig. 1A and B). More-
over, coculture for 18 h did not increase expression of KLRG1,
which is an exhaustion marker (4), on NK cells (Fig. 2D).
Taken together, the observations indicated that the interaction
with HCV-infected cells reduced NK cells’ capacity to de-
granulate against target cells. Degranulation capacity was,
however, slightly recovered, and the difference between NK
cells interacting with uninfected cells and those interacting
with HCV-infected cells was no longer statistically significant
when a high concentration of IL-12, which enhances NK cell
cytotoxicity (37), was added (Fig. 2E).
In addition to degranulation, NK cells may exert cytotoxicity
to HCV-infected target cells by inducing TRAIL expression on
their surfaces (31). TRAIL expression, however, did not in-
crease on NK cells after exposure to HCV-infected cells under
our experimental setting (Fig. 2F).
CD56dim NK cells are responsible for the reduced degran-
ulation. Human NK cells comprise two major subsets.
CD56dim NK cells, which express low-level CD56, mediate
cytotoxicity upon proper recognition of target cells and secrete
a small amount of cytokines. In contrast, CD56bright NK cells,
which express high-level CD56, secrete a large amount of cy-
tokines upon stimulation and acquire cytotoxicity after pro-
longed activation (7, 32). We therefore analyzed the two
subsets separately to identify their respective responses to
HCV-infected cells (Fig. 3). CD56dim NK cells showed a re-
duced degranulation capacity after interaction with HCV-in-
fected cells, as did the total NK cell preparation, and the
differences among groups were significant (Fig. 3A and B, left).
On the contrary, CD56bright NK cells showed insignificant
changes after contact with HCV-infected cells (Fig. 3A and B,
right). Reduced degranulation capacity was, however, no lon-
ger statistically significant in CD56dim NK cells in the presence
of a high concentration of IL-12 (Fig. 3C, left).
NK cells’ ability to produce IFN- is reduced in accordance
with decreased cytotoxic capacity. Since NK cells produce
IFN- to control viral replication (32), we evaluated changes in
IFN- synthesis and secretion by NK cells after exposure to
HCV-infected cells. To exclude the inhibitory effect of hepa-
toma cells on NK cell function, NK cells which interacted with
uninfected or HCV-infected Huh7 or Huh7.5 cells in the ab-
sence of cytokines were used for coculture with K562 cells in
the presence of 1 ng/ml IL-12 or 10 ng/ml IL-12 and 100 ng/ml
IL-15 for 6 h. As expected from previous reports (7), the
simultaneous engagement of activating NK receptors by acti-
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vating ligands on K562 cells and cytokine receptors by proin-
flammatory cytokines induced IFN- production (Fig. 4A).
The exposure of NK cells to the hepatoma cell lines, however,
downregulated IFN- production (Fig. 4A). Moreover, the
interaction of NK cells with HCV-infected cells further re-
duced IFN- synthesis and secretion by NK cells (Fig. 4A and
B). These findings were consistent with the changes in the
cytotoxic capacity of NK cells upon exposure to uninfected or
HCV-infected Huh7 or Huh7.5 cells (Fig. 2A and B).
To identify which NK cell subset is responsible for the re-
duced IFN- production, we analyzed the two NK cell subsets
separately (Fig. 4C). The hepatoma cell lines Huh7 and
Huh7.5 downregulated IFN- production by both NK cell sub-
sets. Reduction of IFN- production after contact with HCV-
infected cells was, however, due mostly to decreased IFN-
production by CD56dim NK cells. This agreed with the results
from degranulation assays, since the decrease in cytotoxicity of
total NK cells was due mainly to the reduced degranulation of
CD56dim NK cells (Fig. 3A and B).
Continuity of NK cell modulation requires persistent cell-
to-cell contact between NK cells and HCV-infected cells. To
determine whether the changes induced in NK cells are revers-
FIG. 1. NK cell cytotoxicity and activation upon direct exposure to HCV-infected cells. Primary human NK cells were cocultured with
uninfected (uninf.) or HCV-infected (inf.) Huh7 or Huh7.5 cells for 4 h. (A) NK cell degranulation upon exposure to HCV-infected cells.
Degranulation was evaluated by measuring the surface expression of CD107a. NK cells directly cocultured with K562 cells were included as a
positive control. Representative contour plots of results for three independent subjects are shown. (B) NK cell activation upon exposure to
HCV-infected cells was evaluated by measuring the surface expression of activation marker CD25. As a negative control, NK cells were cultured
without target cells. Activation upon direct exposure to K562 cells was measured as a positive control. Representative contour plots of results for
three independent subjects are shown. (C) Specific lysis of HCV-infected cells by NK cells. Uninfected or HCV-infected Huh7.5 cells were used
as target cells. Direct lysis of K562 cells was included as a positive control. Percent specific lysis was calculated as follows: (% TO-PRO-3PKH-26
target cells in coculture  % TO-PRO-3PKH-26 target cells in medium)/(% TO-PRO-3PKH-26 target cells in detergent  % TO-PRO-
3PKH-26 target cells in medium)  100. Each point represents the mean  standard deviation (n  3 experiments).
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FIG. 2. Reduced cytotoxic capacity of NK cells after interaction with HCV-infected cells. Primary human NK cells were preincubated with
uninfected or HCV-infected Huh7 or Huh7.5 cells for 18 h and cocultured with K562 cells at a 1:1 ratio for 4 h in the absence of Huh7 or Huh7.5
cells. (A, B) Reduced degranulation capacity of NK cells after interaction with HCV-infected cells. Representative contour plots of results for nine
independent subjects (A) and percentage of CD107a NK cells for all subjects (B) are shown. NK-alone plots for Huh7 and Huh7.5 experiments
are duplicates of the same contour plot (A), and NK-alone columns for Huh7 and Huh7.5 graphs are copies of the same data (B). (C) Decreased
cytolytic capacity of NK cells after exposure to HCV-infected cells. Each point represents the mean  standard deviation (n  3 experiments).
(D) Expression of exhaustion marker KLRG1 on NK cells after an 18-h coculture with uninfected or HCV-infected Huh7 or Huh7.5 cells.
Representative histograms for two independent subjects are shown. (E) Changes in NK cell degranulation capacity after interaction with
HCV-infected cells in the presence of 50 ng/ml IL-12 for 18 h. NK alone columns for Huh7 and Huh7.5 graphs are copies of the same data.
(F) Expression of TRAIL on NK cells after an 18-h coculture with uninfected or HCV-infected Huh7 or Huh7.5 cells. Representative histograms
for two independent subjects are shown.
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FIG. 3. Decreased degranulation of CD56dim NK cells after exposure to HCV-infected cells. (A, B) Degranulation capacities of CD56dim and
CD56bright NK cells were analyzed separately. Representative contour plots of results for seven independent subjects (A) and percentage of
CD107a NK cell subsets for all subjects (B) are shown. (C) Changes in degranulation capacity of NK cell subsets after interaction with
HCV-infected cells in the presence of 50 ng/ml IL-12 for 18 h. NK-alone plots for Huh7 and Huh7.5 experiments are duplicates of the same contour
plot (A), and NK-alone columns for Huh7 and Huh7.5 graphs are copies of the same data (B, C).
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FIG. 4. Reduced IFN- production by NK cells after interaction with HCV-infected cells. (A) Primary human NK cells were preincubated with
uninfected or HCV-infected Huh7 or Huh7.5 cells in the absence of cytokines for 18 h and cocultured with K562 cells at a 1:1 ratio in the presence
of 10 ng/ml recombinant human IL-12 and 100 ng/ml recombinant human IL-15 for 6 h. IFN- production was measured by intracellular staining
of IFN- and flow cytometric analysis. Representative contour plots of the results for three independent subjects are shown. NK-alone plots for
Huh7 and Huh7.5 experiments are duplicates of the same contour plot. (B) Primary human NK cells were preincubated with uninfected or
HCV-infected Huh7 or Huh7.5 cells for 18 h and cocultured with K562 cells at a 1:1 ratio in the presence of 1 ng/ml recombinant human IL-12
for 6 h. IFN- secreted into the culture supernatant was measured by enzyme-linked immunosorbent assay (ELISA). (C) IFN- productions by
CD56dim and CD56bright NK cells were analyzed separately. Representative contour plots of the results for three independent subjects are shown.
NK-alone plots for Huh7 and Huh7.5 experiments are duplicates of the same contour plot.
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ible, NK cells were cocultured with uninfected or HCV-in-
fected Huh7 cells for 18 h and rested for 24 h in the absence of
Huh7 cells. After the rest, degranulation of the NK cells
showed recovery, in that the difference between NK cells ex-
posed to uninfected cells and those exposed to HCV-infected
cells was no longer statistically significant (Fig. 5A).
To investigate whether soluble factors, such as cytokines
secreted by the infected cells, soluble NK ligands released from
the infected cells, and cell-free HCV virions, play a role in the
reduction of NK cell degranulation (9, 14, 25, 36), we cocul-
tured NK cells and HCV-infected cells in adjacent filter wells.
In this system, we found that the degranulation capacity of NK
cells did not change and therefore that the HCV-infected
Huh7 and Huh7.5 cells require cell-to-cell contact with NK
cells to mediate their effects (Fig. 5B). We concluded that
changes in NK cell function require continued cell-to-cell con-
tact between NK cells and HCV-infected cells.
NK ligand expression is unassociated with the functional
modulation of NK cells. Altered expression levels of inhibitory
NK ligands, activating NK ligands, or both on the surface of
HCV-infected target cells may modulate signals for NK cell
activation. Thus, we assessed the expression levels of these
ligands on HCV-infected Huh7 and Huh7.5 cells. To ensure
infection of all cells, Huh7 cells were infected at an MOI of 10.
Huh7.5 cells were infected at an MOI of 1, however, because
higher MOI killed Huh7.5 cells within 3 days of infection.
Nevertheless, about 70% of Huh7.5 cells were positive for the
HCV core at 72 h postinfection, while about 30% of Huh7 cells
were positive for the HCV core (see Fig. S1 in the supplemen-
tal material). The high core positivity observed in Huh7.5 cells
might be due to the retinoic acid-inducible gene I mutation
found in Huh7.5 cells (34).
Three days postinfection, the surface expression levels of
inhibitory ligands, HLA-ABC and HLA-E, and activating li-
gands, MICA/B and ULBPs, were determined. An increase of
inhibitory ligands would inactivate NK cells, and a decrease of
activating ligands would lower the chance of NK cell activation.
The expression of activating ligands, however, did not change
after HCV infection, and ULBP-1 expression on Huh7.5 cells
rather slightly increased after HCV infection (Fig. 6A). The
expression of inhibitory ligands did not change either, regard-
less of cell type (Fig. 6B).
Surface expression of activating receptors on NK cells is
downregulated after interaction with HCV-infected cells. Be-
cause an altered display of NK receptors may affect NK cell
function (15, 25), we evaluated the expression of inhibitory
receptors, such as KIR2DL1, KIR2DL2/3, and NKG2A (Fig.
7A). Coculture with HCV-infected cells did not change the
expression of these NK cell surface proteins. It was indeed
consistent with the results from the cytotoxicity assays, which
suggested that upregulation of inhibitory receptors would not
occur because K562 cells do not express HLA-ABC (ligand for
KIR) and HLA-E (ligand for CD94/NKG2A) (15).
In contrast, the surface expression of activating receptors,
such as NKG2D and NKp30, which are constitutively ex-
pressed on resting NK cells (5), decreased after exposure to
HCV-infected cells (Fig. 7B and C). The expression of
DNAM-1, NKp46, and 2B4, which are other constitutively ex-
pressed activating receptors, did not decrease, except after inter-
play with HCV-infected Huh7.5 cells in the case of DNAM-1 and
NKp46 (Fig. 7D to F). The result suggested that the downregu-
lated surface expression of several constitutively expressed acti-
vating receptors might be associated with the reduction in func-
tional capacity of NK cells after contact with HCV-infected cells.
Correlation between degranulation and activating receptor
expression reveals the effect of receptor downregulation on NK
cell functional modulation. To determine direct correlation
between the downregulation of activating receptors and the
reduction of degranulation capacity, we specifically examined
changes in activating receptor expression on degranulation
competent NK cells, which could express CD107a upon expo-
sure to K562 cells. Since it was likely that the degranulation
changes shown in Fig. 1 were caused when previously degran-
ulation competent NK cells lost their degranulation capacity,
alterations in the frequencies of degranulation competent NK
cells rather than those of total NK cells, which include NK cells
without degranulation capacity, were needed to be examined.
FIG. 5. NK cell modulation requires persistent cell-to-cell contact
of NK cells with HCV-infected cells. (A) Recovery of degranulation.
Primary human NK cells were preincubated with uninfected or HCV-
infected Huh7 cells for 18 h and rested for 24 h in the absence of Huh7
cells. The NK cells were cocultured with K562 cells for 4 h after the
rest. Degranulation was determined by detecting CD107a expression
on NK cells. (B) Degranulation after contact-free coculture. Primary
human NK cells were preincubated with uninfected or HCV-infected
Huh7 cells for 18 h in filter wells to prevent cell-to-cell contact and
cocultured with K562 cells for 4 h. Degranulation was determined by
detecting CD107a expression on NK cells.
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The interaction with HCV-infected Huh7 or Huh7.5 cells
downregulated NKG2D and NKp30 on the surface of degran-
ulation competent NK cells and made them lose degranulation
capacity. The interaction with HCV-infected cells increased
the proportion of double-negative cells at the same time (Fig.
8A and B). Analysis of NK cell subsets showed that CD56dim
NK cells were responsible for the reduction of NKG2D and
NKp30 on the surface of CD107a NK cells (see Fig. S2 in
the supplemental material). Moreover, unlike total NK
cells, the expression of NKG2D and NKp30 was reduced on
the CD107a subset of NK cells after interaction with un-
infected Huh7 or Huh7.5 cells (Fig. 8A and B). The para-
FIG. 6. NK ligand expression on Huh7 and Huh7.5 cells after HCV infection. Huh7 and Huh7.5 cells were infected with HCV at an MOI of
10 and an MOI of 1, respectively. (A) Expression of NK-activating ligands MICA/B, ULBP-1 to -3, and PVR on uninfected or HCV-infected Huh7
and Huh7.5 cells was measured at 3 days postinfection. Representative histograms from three independent experiments are shown. (B) Expression
of NK inhibitory ligands HLA-ABC and HLA-E on uninfected or HCV-infected Huh7 and Huh7.5 cells was measured at 3 days postinfection.
Representative histograms from three independent experiments are shown.
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FIG. 7. NK receptor expression on NK cells after interaction with HCV-infected cells. (A) Expression of NK inhibitory receptors on NK cells
after interaction with HCV-infected cells. Primary human NK cells were cocultured with uninfected or HCV-infected Huh7 or Huh7.5 cells for
18 h, and expression of inhibitory receptors KIR2DL1, KIR2DL2/DL3, and NKG2A on NK cells was determined. Representative histograms for
five independent subjects are shown. (B to F) Downregulation of NK-activating receptors NKG2D, NKp30, and DNAM-1 on the surface of NK
cells after interaction with HCV-infected cells. Primary human NK cells were cocultured with uninfected or HCV-infected Huh7 or Huh7.5 cells
for 18 h, and expression of activating receptors was determined. Frequencies of NKG2D (B), NKp30 (C), DNAM-1 (D), NKp46 (E), and
2B4 (F) NK cells are shown. NK-alone columns for Huh7 and Huh7.5 graphs are copies of the same data (B to F).
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FIG. 8. Correlation of activating receptor downregulation with reduced degranulation. Primary human NK cells were preincubated with
uninfected or HCV-infected Huh7 or Huh7.5 cells for 18 h and cocultured with K562 cells at a 1:1 ratio for 4 h. Interrelation between degranulation
and activating receptor expression was analyzed for NKG2D (A), NKp30 (B), DNAM-1 (C), NKp46 (D), and 2B4 (E). Representative contour
plots of results for five (A to C) or three (D, E) independent subjects are shown. NK-alone plots for Huh7 and Huh7.5 experiments are duplicates
of the same contour plot (A to E).
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doxical increase of NKG2D and NKp30 on the surface of total
NK cells after exposure to uninfected Huh7 or Huh7.5 cells
compared to that of unexposed NK cells (Fig. 7B and C) was
due largely to the increase of NKG2D- or NKp30-expressing
noncytotoxic (CD107a) NK cells. Although the reason for the
increased surface expression of NKG2D and NKp30 on de-
granulation incompetent NK cells was not clear, such upregu-
lation of NKG2D or NKp30 degranulation incompetent NK
cells did not cause any increase in the cytotoxic capacity of total
NK cells (Fig. 8A and B).
Reduced expression of DNAM-1 might be, however, much
less responsible for the HCV-infected-cell-mediated reduction
in degranulation capacity than that of NKG2D and NKp30,
since the frequency of DNAM-1 degranulation competent
NK cells was considerably reduced after interaction with the
uninfected hepatoma cell lines, Huh7 or Huh7.5 cells, and
already quite low even before contact with HCV-infected cells
(Fig. 8C). It appeared, therefore, that DNAM-1 downregula-
tion might be rather involved in the tumor cell-mediated de-
crease of NK cell cytotoxic capacity.
In contrast to NKG2D and NKp30, the expression of
NKp46 and 2B4 did not decrease, and the percentage of
double-negative cells did not increase after interaction with
HCV-infected cells, except a slight increase in the percent-
age of NKp46CD107a NK cells after interaction with
HCV-infected Huh7.5 cells (Fig. 8D and E). The result
suggested that NKp46 and 2B4 might be unassociated with
the observed NK cell cytotoxicity changes.
DISCUSSION
We performed this study to investigate whether HCV causes
functional modulation of NK cells through a direct interplay
with HCV-infected hepatocytes. If the NK cell response to
HCV infection is suppressed, viral containment will be im-
paired, and this may contribute to diminished cellular immune
responses and a high incidence of chronic hepatitis C after
HCV infection (11). Our study showed that the interaction
with HCV-infected cells resulted in a reduced functional ca-
pacity of NK cells. The ability to degranulate, lyse target cells,
and produce and secrete IFN- was impaired, and it was as-
sociated with the downregulated expression of activating re-
ceptors on NK cells.
The frequency of infected cells did not affect the inhibitory
effect of HCV-infected cells, because Huh7 and Huh7.5 cells
showed similar results, though frequencies of HCV core-pos-
itive cells were different from each other. The inhibitory effect
of HCV-infected cells, therefore, may be based on cellular
changes that are induced by HCV infection, because cells that
clear HCV infection spontaneously by 72 h postinfection may
retain HCV-induced changes even after clearance of the virus.
This hypothesis should be, however, investigated in further stud-
ies.
To exclude the inhibitory effect of tumor cells on NK cells,
we separated the NK cells from HCV-infected hepatoma cells
before interaction with K562 cells. This implies that the func-
tional inhibition of NK cells is unassociated with a transient
inhibition of NK cells by the inhibitory NK cell immunological
synapse (iNKIS) (18) formed between NK cells and HCV-
infected cells. The absence of any considerable increase in the
expression of inhibitory ligands on HCV-infected cells sup-
ports the conclusion. Instead, the functional modulation must
correspond to stable changes in regulation, such as activating
receptor downregulation on the NK cell surfaces. The NK cell
degranulation did not last indefinitely, however, which points
to a requirement for sustained cell-to-cell contact between NK
cells and HCV-infected cells.
The functional capacity of resting NK cells is dependent
largely on the surface expression of constitutively expressed
activating receptors. Although there have been discrepancies
among studies, several ex vivo studies showed that NK-activat-
ing receptors are downregulated in HCV infection in vivo. For
example, Nattermann et al. identified that the proportion of
NKp30- and NKp46-expressing NK cells is reduced in patients
with chronic hepatitis C (26), and Sene et al. reported that
NKG2D expression is reduced on circulating NK cells from
patients with chronic hepatitis C (30). In conjunction with our
study, these reports indicate that downregulation of NK-acti-
vating receptors is a plausible mechanism of functional inhibi-
tion of NK cells in HCV infection.
IFN- is the major cytokine that NK cells secrete and is a
critical factor for inhibition of viral replication in the infected
cells (22). Although CD56bright NK cells readily secrete IFN-
after stimulation with proinflammatory cytokines, such as
IL-12 and IL-15, CD56dim NK cells can also secrete IFN-
upon recognition of target cells in the presence of proinflam-
matory cytokines (32). Since CD56dim NK cells are readily
recruited from peripheral blood to the inflammation sites,
whereas CD56bright NK cells are enriched in secondary lym-
phoid organs (32, 37), inhibition of CD56dim NK cells’ ability to
secrete IFN- may be more directly related to uncontrolled
replication of viruses. Our results therefore suggest that
CD56dim NK cells which are recruited to the infection sites and
contact with HCV-infected hepatocytes may lose their capacity
to secrete IFN- in vivo.
The direct correlation of decreased IFN- production with
downregulated activating receptor expression could not be
evaluated, because brefeldin A treatment for intracellular cy-
tokine detection blocked not only IFN- secretion but also
surface expression of activating receptors (data not shown).
The consistency between the results from cytotoxicity assays
and the observations from IFN- assays implies, however, that
the reduction in IFN- secretion by CD56dim NK cells may be
associated with the decrease in activating receptor expression.
It is, in fact, known that concurrent engagement of activating
receptors and cytokine receptors on NK cells induces IFN-
secretion by NK cells (7). A decrease in activating receptor
expression would, therefore, likely be correlated with IFN-
production by CD56dim NK cells. Further investigations are,
however, needed to confirm the relationship.
Although we proposed downregulation of activating recep-
tors as the cause of reduced NK cell functional capacity, inter-
action of immobilized E2 with CD81 might be another possible
answer if E2 could be immobilized on the surface of HCV-
infected hepatocytes. Moreover, other factors, such as cyto-
kines secreted by immune cells or the infected hepatocytes,
may also control NK cell function in addition to direct cell-to-
cell contact between NK cells and HCV-infected hepatocytes.
Our results from experiments using high-dose IL-12 implied
this possibility. Other reports showed that exposure to inhibi-
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tory cytokines, such as IL-10 and transforming growth factor 	
(TGF-	), suppresses NK cell cytotoxicity (30), while chronic
exposure to activating cytokine IFN-
 contributes to the po-
larization of NK cells toward cytotoxicity (1, 27). The fate of
NK cells in HCV infection may be therefore determined by the
integration of signals generated by direct cell-to-cell interac-
tion and cytokine stimulation. Further studies using in vivo
models of HCV infection are needed to identify the outcome
of the integrated signals in various stages of HCV infection.
Thus far, there is no evidence that NK cells are inhibited in
the HCV-infected liver, though our in vitro study suggests that
functional capacity of liver-infiltrating NK cells which inter-
acted with HCV-infected hepatocytes may be reduced in vivo.
Especially in the incubation phase and the acute phase of HCV
infection, it is difficult to investigate whether liver-infiltrating
NK cells are functionally impaired, because liver biopsy during
these phases is impossible due to ethical reasons. We therefore
hope that our study prompts further studies employing chim-
panzee models or humanized mouse models for immunologic
research to assess functional status of liver NK cells in various
phases of HCV infection.
In summary, this study revealed a significant modulation of
NK cell function in HCV infection in vitro, which may be based
on the downregulation of activating receptors, such as NKG2D
and NKp30. In vivo, reduced functional capacity would in prin-
ciple make NK cells fail to prevent HCV replication and
spread of the virus. Further studies that investigate detailed
mechanisms may provide a way to find molecules or signaling
processes which could be targeted to restore NK cell function.
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